2025-07-23 - Analysis Report
Okay, here's a report analyzing Honeywell International Inc. (HON) based on the provided data.

**Report: Honeywell International Inc. (HON) Analysis**

**Company Overview:**  Honeywell International Inc. is a diversified technology and manufacturing company serving customers worldwide with aerospace products, building and industrial control technologies, and performance materials.

**1. Performance vs. S&P 500 (VOO)**

*   **HON Ticker:** HON
*   **HON Cumulative Return:** 50.69%
*   **VOO (S&P 500) Cumulative Return:** 97.07%
*   **Return Disparity:** -47.3%
*   **Relative Disparity:** 4.6 (This indicates HON's underperformance is near the lower end of its historical range relative to VOO.)

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD   | Alpha  | Beta | Cap(B) |
|------------|--------|-------|--------|------|--------|
| 2015-2017  | 38.0%  | 56.2% | 9.0%   | 0.1  | 94.5   |
| 2016-2018  | 22.0%  | 63.2% | 4.0%   | 0.1  | 85.0   |
| 2017-2019  | 42.0%  | 63.2% | 13.0%  | 0.5  | 113.9  |
| 2018-2020  | 51.0%  | 63.2% | 31.0%  | 0.3  | 136.8  |
| 2019-2021  | 48.0%  | 59.4% | 0.0%   | 0.2  | 134.1  |
| 2020-2022  | 34.0%  | 70.8% | 31.0%  | 0.2  | 137.8  |
| 2021-2023  | -10.0% | 70.8% | -28.0% | 0.6  | 134.9  |
| 2022-2024  | -21.0% | 71.7% | -47.0% | 0.6  | 145.3  |
| 2023-2025  | -19.0% | 71.7% | -68.0% | 1.1  | 152.2  |

**Analysis:**

*   **Underperformance:**  HON has significantly underperformed the S&P 500 over the specified period. The large negative disparity of -47.3% highlights this.
*   **Alpha and Beta:**  The Alpha has been volatile, with recent negative Alpha values suggesting HON has underperformed relative to its risk profile. The Beta values are generally low, indicating lower volatility than the market.
*   **CAGR:** While HON has demonstrated positive CAGR in previous years, the recent CAGR values are negative.
*   **MDD:** HON experiences relatively high maximum drawdowns, indicating potential risk.
*   **Cap:** HON demonstrates a increase in its capital over the provided period.

**2. Recent Price Action**

*   **Current Price:** 236.58
*   **Previous Close:** 235.22
*   **Price Change:** 0.58
*   **5-Day Moving Average:** 236.72
*   **20-Day Moving Average:** 234.93
*   **60-Day Moving Average:** 225.19

**Analysis:**

*   The current price is above the 20-day and 60-day moving averages, suggesting a potential upward trend.
*   The 5-day moving average is slightly above the current price.
*   The recent price change of 0.58 (Last-market) suggests a positive movement that has been factored into the analysis.

**3. Technical Indicators and Outlook**

*   **Market Risk Indicator (MRI):** 0.34 (Low Risk)
*   **RSI:** 44.51 (Neutral, neither overbought nor oversold)
*   **PPO:** -0.25 (Slightly negative, indicating a potential weakening trend)
*   **Hybrid Signal:** "cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.34)" (Suggests a cautious approach with a partial buy recommendation)
*   **20-Day Relative Disparity Change:** -3.1 (Short-term downward trend in relative performance)
*   **Expected Return:** -67.7% (Significant underperformance is expected relative to S&P 500 in the long term.)

**Analysis:**

*   The MRI indicates low market risk, but other indicators are less optimistic.
*   The negative expected return is a major concern, suggesting significant underperformance against the S&P 500 if investing for the long term from the current point.

**4. Recent News & Significant Events**

*   **2025-07-21:**  Major business developments, regulatory changes, or market events.
*   **2025-07-20:**  Analyst discussions on recent performance and outlook.
*   **2025-07-22:**  Stock volatility due to recent news, earnings, or executive actions.
*   **2025-07-19:**  Market experts highlight risks and opportunities.

**Analysis:**

*   Recent news suggests volatility and potential impacts from market events, regulatory changes, and analyst opinions. Close monitoring of these factors is essential.

**5. Recent Earnings Analysis**

| 날짜       | EPS  | 매출     |
|------------|------|----------|
| 2025-04-29 | 2.24 | 9.82 B$  |
| 2024-10-24 | 2.17 | 9.73 B$  |
| 2024-07-25 | 2.37 | 9.58 B$  |
| 2024-04-25 | 2.24 | 9.11 B$  |
| 2025-04-29 | 2.24 | 9.11 B$  |

**Analysis:**

*   EPS has fluctuated. The dates for the provided data are not in chronological order. It would be helpful to have the historical trend of EPS to determine if the performance is increasing or decreasing.
*   Revenue has generally increased slightly over the past few quarters.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-03-31   | $9.82B    | 38.54%        |
| 2024-12-31   | $10.09B   | 36.38%        |
| 2024-09-30   | $9.73B    | 38.54%        |
| 2024-06-30   | $9.58B    | 38.85%        |
| 2024-03-31   | $9.11B    | 38.68%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE   |
|--------------|-----------|-------|
| 2025-03-31   | $17.46B   | 8.30% |
| 2024-12-31   | $18.62B   | 6.90% |
| 2024-09-30   | $17.41B   | 8.12% |
| 2024-06-30   | $16.95B   | 9.11% |
| 2024-03-31   | $16.45B   | 8.89% |

**Analysis:**

*   **Revenue:** Revenue has been relatively stable, with a slight increase over the period.
*   **Profit Margin:** Profit margins have remained strong, consistently above 36%.
*   **Equity:** Equity has fluctuated.
*   **ROE:** ROE (Return on Equity) has also fluctuated, showing a slight decrease in the most recent quarter.

**7. Overall Summary & Conclusion**

Based on the provided data, HON presents a mixed investment picture:

*   **Underperformance:**  HON has significantly underperformed the S&P 500, and the negative expected return raises concerns about future relative performance.
*   **Technicals:** Technical indicators are mixed, with a cautious buy recommendation from the hybrid signal, but potential weakening trend reflected in the PPO.
*   **Financials:**  Revenue and profitability appear healthy, but fluctuations in equity and ROE warrant further investigation.
*   **News:** Recent news suggests volatility and potential impacts from market events, regulatory changes, and analyst opinions.

**Overall Recommendation:**

Given the significant underperformance against the S&P 500, negative expected return, and mixed technical signals, a cautious approach is warranted. Investors should carefully monitor upcoming news, analyst reports, and further financial data before making any investment decisions. Further research is needed to understand the drivers behind the underperformance and the potential for future recovery.
